These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 2939095)

  • 1. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyribonucleotide metabolism and cyclic AMP resistance in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Gudas LJ; Nodzenski E
    J Cell Physiol; 1987 Feb; 130(2):262-9. PubMed ID: 3029148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of phosphonoformic acid on wild type and mutant S49 cell lines.
    Albert DA; Gudas LJ
    Adv Exp Med Biol; 1986; 195 Pt B():185-9. PubMed ID: 2945406
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
    Albert DA; Nodzenski E; Yim G; Kowalski J
    J Cell Physiol; 1990 May; 143(2):251-6. PubMed ID: 2159014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts.
    Kucera R; Brown CL; Paulus H
    J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonucleotide reductase activity and deoxyribonucleoside triphosphate metabolism during the cell cycle of S49 wild-type and mutant mouse T-lymphoma cells.
    Albert DA; Gudas LJ
    J Biol Chem; 1985 Jan; 260(1):679-84. PubMed ID: 2981227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Nodzenski E
    Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity.
    Fridland A
    Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
    Kinahan JJ; Otten M; Grindey GB
    Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
    Lewis WH; Wright JA
    J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
    Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells.
    Eriksson S; Skog S; Tribukait B; Wallström B
    Exp Cell Res; 1987 Jan; 168(1):79-88. PubMed ID: 3096753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of ribonucleotide reduction in nucleotide-permeable hamster cells.
    Lewis WH; Kuzik BA; Wright JA
    J Cell Physiol; 1978 Mar; 94(3):287-98. PubMed ID: 621224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual sensitivity to bleomycin and joint resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine of mouse FM3A cell mutants with altered ribonucleotide reductase and thymidylate synthase.
    Ayusawa D; Iwata K; Seno T
    Cancer Res; 1983 Feb; 43(2):814-8. PubMed ID: 6184158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
    Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
    Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of deoxycytidine rescue of thymidine toxicity in human T-leukemic lymphocytes.
    Fox RM; Tripp EH; Tattersall MH
    Cancer Res; 1980 May; 40(5):1718-21. PubMed ID: 6989492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxyribonucleotide pools in mouse-fibroblast cell lines with altered ribonucleotide reductase.
    Meuth M; Aufreiter E; Reichard P
    Eur J Biochem; 1976 Dec; 71(1):39-43. PubMed ID: 1087605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG; Carter GL
    Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.